Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Glucocorticoid-Induced Osteoporosis

  |  

Osteoporosis is a condition of weak bone caused by a loss of bone mass and a change in bone structure. Glucocorticoid-induced osteoporosis is a form of osteoporosis caused by taking glucocorticoid medications, such as prednisone (Deltasone, Orasone, etc.), prednisolone (Prelone), dexamethasone (Decadron, Hexadrol), and cortisone (Cortone Acetate). These medications are used to help control many rheumatic diseases, including RA, systemic lupus erythematosus, and polymyalgia rheumatica.

Sneak Peak at the 2008 Annual Scientific Meeting

  |  

The 2007 ACR/ARHP Annual Scientific Meeting was well received by attendees, and the ACR and the ARHP are building on that foundation by offering a variety of in-depth sessions at the 2008 meeting in San Francisco on October 24–29.

Tips to Access Journals Online

  |  

Online access to Arthritis & Rheumatism and Arthritis Care & Research is a member benefit of the ACR and the ARHP. In order to use this benefit, you must activate your online access by creating a login specifically for the journals through a one-time registration process. Here is a Q&A to help you access journals online.

New Advance Beneficiary Notice

  |  

CMS has replaced the general and lab advanced beneficiary notice with the Advance Beneficiary Notice (ABN) of Non-coverage. The new titled notice requires physicians and other healthcare providers to use a new form when services are not expected to be covered by Medicare.

Boost Revenue with Denials Management, Appeals

  |  

Denials management and appeals are the two most underestimated processes in rheumatology offices. Most practices lose thousands of dollars every year because they are not following up or writing off denied claims correctly.